POWELL FRED M enters LAVA THERAPEUTICS NV with 65K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/2/2025ACC: 0001415889-25-000007
Officer· Chief Financial Officer
Since Jan 2025
65K
Baseline shares
100% direct
65K
Direct ownership
1 position
315.95K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Shares
DirectShares owned65K
Total
65K direct65K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 65K | Direct |
| Total | 65K | 65K direct |
Derivative Holdings2
Share Options (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
195K
Shares owned
N/A
Exercise price
4.38
Expiration
—
Exercise window
—
Share Options (Right to Buy)
DirectUnderlying security
Common Shares
Underlying shares
120.95K
Shares owned
N/A
Exercise price
1.59
Expiration
—
Exercise window
—
Total
Underlying
315.95K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Share Options (Right to Buy) Direct | Common Shares | 4.38 | — | — | 195K | N/A |
| Share Options (Right to Buy) Direct | Common Shares | 1.59 | — | — | 120.95K | N/A |
| Total | 315.95K | 0.00 | ||||